The GAPP Project is funded by the EU-FP7 with the aim to improve the quality of life in children affected by chronic pain. These patients are treated in most cases with drugs which are not authorised for paediatric use. Participants will conduct controlled clinical trials investigating dosage, efficacy and safety of gabapentin for the treatment of paediatric pain.
We are pleased to announce that two other French clinical centres have been involved in the GABA-1 study. The GABA-1 study has already been approved […] Read more
Please subscribe to the GAPP Project newsletter to receive our latest updates.